June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
Participants’ experiences in a clinical trial for vision restoration: Motivation to participate, visual perception and functional use, and experience of loss following termination
Author Affiliations & Notes
  • Frank Lane
    Pyschology, Illinois Insitute of Technology, Chicago, IL
  • Philip Troyk
    Biomedical Engineering, Illinois Insitute of Technology, Chicago, IL
  • Kristian Nitsch
    Pyschology, Illinois Insitute of Technology, Chicago, IL
  • Footnotes
    Commercial Relationships Frank Lane, None; Philip Troyk, Sigenics, Inc (I), Sigenics, Inc (E); Kristian Nitsch, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5317. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Frank Lane, Philip Troyk, Kristian Nitsch; Participants’ experiences in a clinical trial for vision restoration: Motivation to participate, visual perception and functional use, and experience of loss following termination. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5317.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: At the 2012 World Congress on Artificial Vision, more than 12 investigators reported on the status of their vision implant designed to restore visual percepts for people who are blind. Many of the investigations have moved to human clinical trials, yet, to date little exists in the literature on the experiences of participants in visual prosthesis trials. This presentation is the first report on the experiences of 12 of the 16 recipients implanted with a surface-cortex implant by William Dobelle.

Methods: In-depth qualitative interviews of individuals who received a Dobelle cortical visual prosthesis were conducted. Eleven recipients, and the parents of one deceased recipient, were contacted and invited to an interview, so that they could describe their experiences of participation in the Dobelle study. Informed consent was obtained from all participants. All interviews were audio or video recorded, professionally transcribed, and qualitatively analyzed using MAXQDA software.

Results: Analyses of participant interviews revealed motivation that has not been previously documented. While restoration of vision emerged as the strongest motivator, altruism, excitement associated with participating in “ground breaking” research, and the importance of hope were notable; these have not been reported in the literature and are not well understood. While some of the recipients reported no functional benefit from the implant, others described perceiving a range of phosphenes with as few as two and as many as 119. Participants describe functional benefits across this range of phosphenes. Individuals who experienced restored visual perception also experienced feelings of loss upon project termination.

Conclusions: The experiences of former implantable device users should be a critical component of every implantable device project, especially when considering the risk/benefit ratio. The Dobelle recipients interviewed in this study have provided valuable information on the importance of including self-reported feedback from participants in clinical trials. These interview results are being used to develop a framework to prepare for the screening and informed consent of future visual prosthesis human implantation trials.

Keywords: 669 quality of life • 755 visual cortex • 468 clinical research methodology  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.